Posted on December 3, 202512/3/25
New Direct-to-Employer Access Model Provides Options for Employers to Improve Access to Weight Loss Medications
Posted on October 16, 202510/16/25
Let’s Be DIRECT: We Have An Access and Affordability Problem to Solve
Posted on October 9, 202510/9/25
Navigating the New HTA Landscape: Pamela Vo on Strategic Evidence Planning
Posted on October 1, 202510/1/25
Brave New Commercialization World: Reimagining Global Launch Strategies in Life Sciences
Posted on September 30, 20259/30/25
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Posted on September 30, 20259/30/25
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Posted on September 11, 20259/11/25
The Most-Favored-Nation Model: Global Benchmark or Global Risk?
Posted on September 10, 20259/10/25
The Evolution of the 340B Rebate Model: Maintaining Patient Access while Minimizing Duplicate Discounts
Posted on September 10, 20259/10/25
2026 CMS Proposed Rule: BFSF Changes and Potential Risks for Pharma Manufacturers
Posted on September 10, 20259/10/25